Tekmira Cleared to Begin Second Phase I Trial of siRNA Cancer Drug
August 11, 2011
Tekmira Cleared to Begin Second Phase I Trial of siRNA Cancer Drug
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tekmira Releases Phase I Cancer Drug Data, Plans Phase II Trial in Neuroendocrine Tumors
April 11, 2013 / Gene Silencing News - Tekmira to Present Cancer Drug Data at AACR, Aims for Phase II by Year-End
March 28, 2013 / Gene Silencing News - Tekmira Provides Pipeline Update, Eyes Agricultural Market
February 14, 2013 / Gene Silencing News - Tekmira Says Pipeline on Track Heading into Q4; Holds Course on Alnylam Litigation
November 10, 2011 / Gene Silencing News - Alnylam Presents Phase I Data at ASCO Showing Liver Cancer Drug Well Tolerated
June 9, 2011 / Gene Silencing News